PLC β 1 Antibodies

Santa Cruz Biotechnology features a diverse variety of PLC β 1 monoclonal antibodies for research in cell signaling and related pathways. PLC β 1 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phospholipase C beta 1 (PLC β 1) plays a crucial role in the phosphoinositide signaling pathway, mediating the hydrolysis of phosphatidylinositol 4,5-bisphosphate to generate inositol trisphosphate and diacylglycerol. This process is essential for various cellular functions, including cell proliferation, differentiation, and apoptosis. Understanding PLC β 1 function is vital for elucidating its involvement in numerous physiological and pathological processes, including cancer and cardiovascular diseases. Research has shown that PLC β 1 signaling influences calcium mobilization and protein kinase C activation. Recent studies have highlighted the significance of PLC β 1 in neuronal development and synaptic plasticity. Additionally, PLC β 1 has emerged as a potential therapeutic target in various disease models. Santa Cruz Biotechnology monoclonal antibodies for PLC β 1 enable researchers worldwide to advance scientific understanding of cellular signaling mechanisms and disease pathways.